Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Silke Lutz has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11715329

USES OF DGAT1 INHIBITORS

IPC classification:
A61K 31/42
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature